Delnoy B, Coelho AI, Rubio-Gozalbo ME. Current and future treatments for classic galactosemia. J Pers Med. 2021;11(2):75. doi:10.3390/jpm11020075
Ebrahimi EA, Ghazala SA, et al. Structural analysis of missense mutations in galactokinase 1 (GALK1) leading to galactosemia type-2. J Cell Biochem. 2018;119(9):7585-7598. doi:10.1002/jcb.27097
Pasquali M, Yu C, Coffee B. Laboratory diagnosis of galactosemia: A technical standard and guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018;20(1):3-11. doi:10.1038/gim.2017.172
Rubio-Gozalbo ME, Derks B, Das AM, et al. Galactokinase deficiency: Lessons from the GalNet registry. Genet Med. 2021;23(1):202-210. doi:10.1038/s41436-020-00942-9
Welling L, Bernstein LE, Berry GT, et al. International clinical guideline for the management of classical galactosemia: Diagnosis, treatment, and follow-up. J Inherit Metab Dis. 2017;40(2):171-176. doi:10.1007/s10545-016-9990-5


